21 August 2025

Accelerate Clonality and MRD Testing with MiSeq i100

Invivoscribe’s LymphoTrack® Assays* are now available for Illumina’s cost-efficient MiSeq™ i100 platform – enabling rapid, high-quality detection and tracking of clonal rearrangements.


LymphoTrack Assays & Workflow

Invivoscribe offers a suite of research use only (RUO) kits targeting seven common gene rearrangements—including IGH (Leader and FR1/2/3), IGK, TRB and TRG—to support clonality identification, somatic hypermutation determination and measurable residual disease (MRD) assessment.  All assays feature indexed master mixes and a streamlined one-step multiplex PCR that allows up to 24 samples and any combination of targets per run.  Resulting FASTQ files are analyzed by the RUO LymphoTrack Software – MiSeq* and/or  LymphoTrack MRD Software* which generates PDF reports and tabulated output files for result interpretation and intuitive data visualization.

Comparative Performance: MiSeq vs. MiSeq i100

Invivoscribe constructed a seven-target library from contrived clonal and polyclonal DNA dilutions to compare the original MiSeq (with v3 Standard-SBS chemistry) against Illumina’s MiSeq i100 (using XLEAP-SBS chemistry). Key findings include:

  • Run Time: MiSeq i100 completed 2×300 bp paired-end sequencing in ~14 hours—nearly 4x faster than the ~53 hours needed on MiSeq.
  • Output & Quality: Both systems generated similar data volumes (32–34 million pass-filter reads; ~20 Gb output). However, the MiSeq i100 achieved a higher Q30 score (96.9% vs. 77.0%), reflecting enhanced sequencing accuracy.
  • Data Concordance: All targets exceeded the 20,000-read validity threshold on both platforms, and V- and J-gene assignments were fully concordant.  Top-percent reads for each clonal sequence were virtually identical (R² > 0.99 across all seven targets).

Implications for the Laboratory

By combining RUO LymphoTrack Assays with the more efficient MiSeq i100 workflow, laboratories can accelerate turnaround times—achieving same-day results—without compromising data quality. The MiSeq i100 is a cost-effective solution for small- to medium-sized labs seeking faster NGS-based sensitivity and performance.  Coupled with the user-friendly LymphoTrack Software suite, this integrated solution empowers investigators to detect clonality and monitor MRD with unprecedented speed, sensitivity and specificity supporting precision diagnostics and research in hematological malignancies.

 *For Research Use Only; not for use in diagnostic procedures.

Related products

Product NameCatalog Number
LymphoTrack® IGHV Leader Somatic Hypermutation Assay Kit A – MiSeq7-121-0059
LymphoTrack® IGH FR1 Assay Kit A – MiSeq7-121-0009
LymphoTrack® IGH FR2 Assay Kit A – MiSeq7-121-0089
LymphoTrack® IGH FR3 Assay Kit A – MiSeq7-121-0109
LymphoTrack® IGK Assay Kit A – MiSeq7-122-0009
LymphoTrack® TRB Assay Kit A – MiSeq7-225-0009
LymphoTrack® TRG Assay Kit A – MiSeq7-227-0019
LymphoTrack® IGH FR1/2/3 Assay Kit A – MiSeq7-121-0129
LymphoTrack® Software – MiSeq7-500-0009
LymphoTrack® MRD Software7-500-0008

Accelerate Clonality and MRD Testing with MiSeq i100

Related articles

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you

Support Us at the Reuma Light Walk!

October 11th – Let’s light the way together.

Find out more
Need help? Contact our technical support
Contact